Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia

2017255 citationsJournal Articlehybrid Open Access

Authors

Heidi Taipale · University of Eastern Finland

Ellenor Mittendorfer‐Rutz · Karolinska Institutet

Kristina Alexanderson · Karolinska Institutet

Abstract

Among patients with schizophrenia, LAI use is associated with an approximately 30% lower risk of death compared with oral agents. SG LAIs and oral aripiprazole are associated with the lowest mortality.

Topics & Keywords

Schizophrenia research and treatment Bipolar Disorder and Treatment Mental Health and Psychiatry

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Schizophrenia Research

Volume 197, pp. 274-280

DOI: 10.1016/j.schres.2017.12.010

Field-Weighted Citation Impact: 13.28